Literature DB >> 11928136

Physical activity as a mediator between dyspnea and fatigue in patients with chronic obstructive pulmonary disease.

K Woo1.   

Abstract

A cross-sectional design was used to examine the mediating effect of physical activity between dyspnea and fatigue in patients with chronic obstructive pulmonary disease (COPD). Dyspnea was measured using a vertical visual analogue scale, fatigue using the Profile of Mood States-Fatigue subscale, and physical activity using the 6-minute-walk (6MW) test. A convenience sample of 17 male and 22 female patients with COPD provided data for analysis. The sample was characterized by relatively high forced expiratory volume in 1 second (FEV1) of predicted normal values, indicating mild lung impairment and high mean levels of fatigue and dyspnea. Controlling for age and FEV1, dyspnea, physical activity, and fatigue were significantly interrelated. Results of the regression analysis suggested the mediating function of physical activity between dyspnea and fatigue. Limitations and suggestions for practice and future research are presented.

Entities:  

Mesh:

Year:  2000        PMID: 11928136

Source DB:  PubMed          Journal:  Can J Nurs Res        ISSN: 0844-5621


  3 in total

1.  Fatigue in patients with COPD participating in a pulmonary rehabilitation program.

Authors:  Cindy J Wong; Donna Goodridge; Darcy D Marciniuk; Donna Rennie
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-10-05

Review 2.  End of life care in chronic obstructive pulmonary disease: in search of a good death.

Authors:  Anna Spathis; Sara Booth
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

3.  A comparison of muscle strength and endurance, exercise capacity, fatigue perception and quality of life in patients with chronic obstructive pulmonary disease and healthy subjects: a cross-sectional study.

Authors:  Ebru Calik-Kutukcu; Sema Savci; Melda Saglam; Naciye Vardar-Yagli; Deniz Inal-Ince; Hulya Arikan; Zeynep Aribas; Ozge Ozer; Meral Bosnak-Guclu; Lutfi Coplu
Journal:  BMC Pulm Med       Date:  2014-01-27       Impact factor: 3.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.